Fideicomiso Irrevocable F/2061 FHipo (FHIPO14) fair value: what the stock is really worth
As of Sep 23, 2026: fair value of Fideicomiso Irrevocable F/2061 FHipo MXN 3.19, price MXN 14.18, upside -77.5%, quality 49 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Watch Fideicomiso Irrevocable F/2061 FHipo for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 24, 2026.
How to read this chart
60‑month range 8.29 MXN – 15.23 MXN · fair‑value band 2.92 MXN – 4.19 MXN · the 14.18 MXN price screens above the 3.19 MXN fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 24, 2026.
Follow Fideicomiso Irrevocable F/2061 FHipo in your weekly email
Every Wednesday you see whether Fideicomiso Irrevocable F/2061 FHipo is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Fideicomiso Irrevocable F/2061 FHipo engages in acquiring, originating, co-participating, and managing mortgage portfolios in Mexico. The company was incorporated in 2014 and is based in Mexico City, Mexico.
Stock analysis
Fideicomiso Irrevocable F/2061 FHipo (FHIPO14) currently trades at 14.18 MXN, while our model-based Fair Value estimate is 3.19 MXN, implying the stock looks roughly 344.4% overvalued today.
Show more
Valuation
Bull case: the Multiples group reads highest at a median of 6.73 MXN per share, and 0 of the 6 models we run sit above the 14.18 MXN price.
Bear case: the Dividend Discount group reads lowest at 0.5800 MXN, and 6 of the 6 models stay below the price. Evidence for this calculation is low.
Scenario range: 2.92 MXN (bear) to 4.19 MXN (bull), the price of 14.18 MXN sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 49/100 (below-average quality), in the Financial Services sector.
Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.
Fideicomiso Irrevocable F/2061 FHipo reported revenue of 7.3B MXN in FY2023 versus 4.4B MXN in FY2021, a compound +28.7%/yr. Reported net income was 965M MXN in FY2023, compounding +15.6%/yr from FY2021.
Key figures
Market cap 34.9B MXN (≈ $2.0B) · P/E ratio 26.8 · P/S ratio 3.55 · EPS (TTM) 0.5300 MXN · Dividend yield 7.5% · Net margin 13.3% · Return on equity 0.0% · Return on assets 0.0%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 46 out of 100 (low confidence).
What moves the price
The share trades about 7% below its 52-week high and 20% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Financial Services peers we cover trades at −38% fair-value upside, at −78%, FHIPO14 screens richer than that median.
Fair Value models
The price assumes far more growth than our models allow for, so the models scatter widely (0.5800 MXN to 13.85 MXN). Read the Fair Value as a cautious anchor, not a price target; the Growth Forecast section shows what the price assumes.
Bear 2.92 MXNFair Value 3.19 MXNBull 4.19 MXN
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.50/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: only 3 usable fiscal years, at least 4 required
Compare Fideicomiso Irrevocable F/2061 FHipo with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Banks - Regional · 1074 stocks
Beats the industry median on 2/10 measures
Overall it trails its industry peers.
Valuation
Quality Score44 · Bottom 25%
Fair Value upside−75% · Bottom 25%
Profitability
Return on assets0% · Bottom 25%
Net margin (TTM)−1% · Bottom 25%
Operating margin (TTM)26% · Below median
Growth and dividend
Revenue growth−11% · Bottom 25%
Dividend yield (TTM)7.5% · Top 25%
Valuation Multiplesvs Banks - Regional median · lower = cheaper
P/E (TTM)26.8× · Priciest 25%
P/B0.23× · Cheapest 25%
P/S (TTM)3.78× · Pricier than median
Strength profile in five axes (Snowflake)
This stockSector peers
VALUE (fair-value potential)0· sector 11
FUTURE (revenue growth)0· sector 45
PAST (return on equity)0· sector 41
HEALTH (low debt)0· sector 85
DIVIDEND (yield)100· sector 53
VALUE 0: the price sits above our fair-value range.
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Is Fideicomiso Irrevocable F/2061 FHipo (FHIPO14) overvalued or undervalued?
As of Sep 24, 2026, our model estimates a fair value of 3.19 MXN versus a price of 14.18 MXN, about −78% upside (overvalued).
What is the fair value of FHIPO14?
Our model-based fair value for Fideicomiso Irrevocable F/2061 FHipo is 3.19 MXN (as of Sep 24, 2026), built from audited fundamentals. The current price: 14.18 MXN.
What is the quality score of FHIPO14?
Fideicomiso Irrevocable F/2061 FHipo has a Quality Score of 49/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Fideicomiso Irrevocable F/2061 FHipo (FHIPO14)?
Our model-based price target is the fair value of 3.19 MXN (as of Sep 24, 2026) from 6 valuation models. Cautious scenario 2.92 MXN, optimistic scenario 4.19 MXN. It is a calculation from audited fundamentals, not an analyst target.
What is the Fideicomiso Irrevocable F/2061 FHipo stock forecast for 2026?
Our models put fair value at 3.19 MXN, about −78% upside versus a price of 14.18 MXN (overvalued). Cautious scenario 2.92 MXN, optimistic scenario 4.19 MXN. The calculation is refreshed regularly with new filings.
Does Fideicomiso Irrevocable F/2061 FHipo pay a dividend?
Fideicomiso Irrevocable F/2061 FHipo currently shows a dividend yield of about 7.53% relative to its recent price (as of Sep 24, 2026).
What is the intrinsic value of Fideicomiso Irrevocable F/2061 FHipo (FHIPO14)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Fideicomiso Irrevocable F/2061 FHipo it is 3.19 MXN per share (as of Sep 24, 2026), against a price of 14.18 MXN. It is the blended result of 6 valuation models (cash flow, earnings, asset, dividend).
Is Fideicomiso Irrevocable F/2061 FHipo stock overvalued or undervalued in 2026?
As of Sep 24, 2026, FHIPO14 trades above its calculated fair value: price 14.18 MXN, fair value 3.19 MXN, a gap of about −78% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of FHIPO14?
No. The price is what the market pays today (14.18 MXN); the fair value is what the company's own numbers justify (3.19 MXN). For Fideicomiso Irrevocable F/2061 FHipo the two are 10.99 MXN per share apart. That gap is exactly why we show both numbers side by side.
How much is Fideicomiso Irrevocable F/2061 FHipo worth?
The market values Fideicomiso Irrevocable F/2061 FHipo at about 34.9B MXN (market capitalisation, as of Sep 24, 2026). Per share that is 14.18 MXN; our models calculate a fair value of 3.19 MXN per share.
What do the bullish and bearish scenarios say about FHIPO14?
Our models span a range for Fideicomiso Irrevocable F/2061 FHipo: cautious scenario 2.92 MXN, base 3.19 MXN, optimistic 4.19 MXN per share (as of Sep 24, 2026, price 14.18 MXN). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of FHIPO14?
Fideicomiso Irrevocable F/2061 FHipo trades at a price-to-earnings ratio of 26.8 (as of Sep 24, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of 3.19 MXN is built from several models across several years. Other multiples: P/B 0.2, P/S 3.8.
How solid is the balance sheet of Fideicomiso Irrevocable F/2061 FHipo (FHIPO14)?
Balance-sheet figures for Fideicomiso Irrevocable F/2061 FHipo (as of Sep 24, 2026): return on equity 0.0%. They feed the Quality Score of 49/100, which measures business quality independently of the share price.
How far is FHIPO14 from its 52-week high?
Fideicomiso Irrevocable F/2061 FHipo trades at 14.18 MXN, about 7% below its 52-week high of 15.23 MXN and 20% above the low of 11.83 MXN (as of Sep 23, 2026). Distance from the high says nothing about value: that is what the fair value of 3.19 MXN is for.
Which stocks are comparable to Fideicomiso Irrevocable F/2061 FHipo?
From the same area (Financial Services) we also value DBS Group, China Merchants Bank Co, Intesa Sanpaolo S.p.A, HDFC Bank Limited, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Fideicomiso Irrevocable F/2061 FHipo stock attractive at the current price?
The data as of Sep 24, 2026: price 14.18 MXN, calculated fair value 3.19 MXN (−78%), Quality Score 49/100, from 6 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of FHIPO14 calculated?
We run Fideicomiso Irrevocable F/2061 FHipo through 6 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of 3.19 MXN, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.1 % above its aggregate fair value. Fideicomiso Irrevocable F/2061 FHipo itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Fideicomiso Irrevocable F/2061 FHipo (FHIPO14)?
The closing price on Sep 23, 2026 was 14.18 MXN. Our model-based fair value is 3.19 MXN, about −78% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Fideicomiso Irrevocable F/2061 FHipo right now?
The price sits above even our optimistic bull case (4.19 MXN). The favourable scenario is already priced in. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. Solid but not exceptional quality (49/100) and above fair value, neither a clear bargain nor a standout compounder. For a financial, book-value and earnings-based methods matter more than a cash-flow DCF, which fits banks and insurers poorly.
Key figures of Fideicomiso Irrevocable F/2061 FHipo
How large is the market capitalisation of Fideicomiso Irrevocable F/2061 FHipo (FHIPO14)?
The market capitalisation of Fideicomiso Irrevocable F/2061 FHipo is 34.9B MXN (≈ $2.0B). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Fideicomiso Irrevocable F/2061 FHipo (FHIPO14)?
The price-to-sales ratio of Fideicomiso Irrevocable F/2061 FHipo is 3.55 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Fideicomiso Irrevocable F/2061 FHipo (FHIPO14)?
Earnings per share at Fideicomiso Irrevocable F/2061 FHipo are 0.5300 MXN (price ÷ EPS = P/E 26.8). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Fideicomiso Irrevocable F/2061 FHipo (FHIPO14)?
The dividend yield of Fideicomiso Irrevocable F/2061 FHipo is 7.5%. Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Fideicomiso Irrevocable F/2061 FHipo (FHIPO14)?
The net margin of Fideicomiso Irrevocable F/2061 FHipo is 13.3% (fiscal year 2023). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Fideicomiso Irrevocable F/2061 FHipo (FHIPO14)?
The return on equity (ROE) of Fideicomiso Irrevocable F/2061 FHipo is 0.0% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the return on assets of Fideicomiso Irrevocable F/2061 FHipo (FHIPO14)?
The return on assets (ROA) of Fideicomiso Irrevocable F/2061 FHipo is 0.0% (last twelve months). Profit relative to everything the company owns. Harder to inflate than return on equity because debt does not boost it.
What is the operating margin of Fideicomiso Irrevocable F/2061 FHipo (FHIPO14)?
The operating margin of Fideicomiso Irrevocable F/2061 FHipo is 26.2% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Fideicomiso Irrevocable F/2061 FHipo (FHIPO14)?
Revenue at Fideicomiso Irrevocable F/2061 FHipo is growing −10.5% versus a year earlier. How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Fideicomiso Irrevocable F/2061 FHipo (FHIPO14)?
Earnings per share at Fideicomiso Irrevocable F/2061 FHipo are growing −62.7% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does Fideicomiso Irrevocable F/2061 FHipo (FHIPO14) generate?
The free cash flow of Fideicomiso Irrevocable F/2061 FHipo is −2.1B MXN (fiscal year 2023). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does Fideicomiso Irrevocable F/2061 FHipo (FHIPO14) carry?
The net debt of Fideicomiso Irrevocable F/2061 FHipo is 2.9B MXN (fiscal year 2023). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Fideicomiso Irrevocable F/2061 FHipo in the live analysis
One click puts Fideicomiso Irrevocable F/2061 FHipo on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
